NCT03900572 2023-04-13A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant VaccineShanghai Zerun Biotechnology Co.,LtdPhase 1 Completed90 enrolled
NCT05680454 2023-01-17A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV VaccineBeijing Health Guard Biotechnology, IncPhase 1 Completed160 enrolled